Shin Poong Pharm.Co.Ltd. - Asset Resilience Ratio

Latest as of December 2025: 6.83%

Shin Poong Pharm.Co.Ltd. (019170) has an Asset Resilience Ratio of 6.83% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shin Poong Pharm.Co.Ltd. (019170) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

₩24.07 Billion

≈ $16.31 Million USD Cash + Short-term Investments

Total Assets

₩352.47 Billion

≈ $238.86 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2025)

This chart shows how Shin Poong Pharm.Co.Ltd.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 019170 current and non-current assets.

Liquid Assets Composition Over Time

This chart breaks down Shin Poong Pharm.Co.Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 019170 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩24.07 Billion	6.83%
Total Liquid Assets	₩24.07 Billion	6.83%

Asset Resilience Insights

Limited Liquidity: Shin Poong Pharm.Co.Ltd. maintains only 6.83% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shin Poong Pharm.Co.Ltd. Industry Peers by Asset Resilience Ratio

Compare Shin Poong Pharm.Co.Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	11.60%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	4.31%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Avadel Pharmaceuticals PLC NASDAQ:AVDL	Drug Manufacturers - Specialty & Generic	5.90%

Annual Asset Resilience Ratio for Shin Poong Pharm.Co.Ltd. (2003–2025)

The table below shows the annual Asset Resilience Ratio data for Shin Poong Pharm.Co.Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.83%	₩24.07 Billion ≈ $16.31 Million	₩352.47 Billion ≈ $238.86 Million	+2.60pp
2024-12-31	4.23%	₩14.47 Billion ≈ $9.81 Million	₩342.09 Billion ≈ $231.83 Million	-0.56pp
2023-12-31	4.79%	₩16.78 Billion ≈ $11.37 Million	₩350.08 Billion ≈ $237.25 Million	+0.86pp
2022-12-31	3.93%	₩14.23 Billion ≈ $9.64 Million	₩361.54 Billion ≈ $245.01 Million	-12.64pp
2021-12-31	16.57%	₩65.07 Billion ≈ $44.09 Million	₩392.58 Billion ≈ $266.05 Million	-11.11pp
2020-12-31	27.68%	₩134.84 Billion ≈ $91.38 Million	₩487.15 Billion ≈ $330.13 Million	+16.35pp
2019-12-31	11.33%	₩43.07 Billion ≈ $29.19 Million	₩380.11 Billion ≈ $257.60 Million	+3.61pp
2018-12-31	7.72%	₩29.42 Billion ≈ $19.94 Million	₩380.95 Billion ≈ $258.17 Million	+2.78pp
2017-12-31	4.94%	₩19.06 Billion ≈ $12.91 Million	₩385.61 Billion ≈ $261.32 Million	-1.04pp
2016-12-31	5.98%	₩24.90 Billion ≈ $16.88 Million	₩416.49 Billion ≈ $282.25 Million	+5.10pp
2015-12-31	0.88%	₩3.62 Billion ≈ $2.45 Million	₩410.73 Billion ≈ $278.35 Million	+0.19pp
2014-12-31	0.70%	₩2.85 Billion ≈ $1.93 Million	₩409.30 Billion ≈ $277.37 Million	+0.52pp
2013-12-31	0.18%	₩709.30 Million ≈ $480.68K	₩398.35 Billion ≈ $269.96 Million	-0.52pp
2012-12-31	0.70%	₩2.66 Billion ≈ $1.80 Million	₩379.68 Billion ≈ $257.30 Million	+0.41pp
2011-12-31	0.29%	₩1.11 Billion ≈ $749.53K	₩378.50 Billion ≈ $256.50 Million	-0.54pp
2010-12-31	0.83%	₩2.66 Billion ≈ $1.80 Million	₩320.93 Billion ≈ $217.49 Million	+0.75pp
2009-12-31	0.07%	₩230.00 Million ≈ $155.87K	₩310.15 Billion ≈ $210.19 Million	-0.60pp
2007-12-31	0.68%	₩1.47 Billion ≈ $996.20K	₩217.16 Billion ≈ $147.17 Million	+0.18pp
2006-12-31	0.49%	₩990.00 Million ≈ $670.91K	₩201.07 Billion ≈ $136.26 Million	+0.36pp
2005-12-31	0.14%	₩260.00 Million ≈ $176.20K	₩190.07 Billion ≈ $128.81 Million	-0.50pp
2004-12-31	0.64%	₩1.12 Billion ≈ $759.01K	₩174.77 Billion ≈ $118.44 Million	+0.56pp
2003-12-31	0.09%	₩142.54 Million ≈ $96.60K	₩166.19 Billion ≈ $112.63 Million	--

pp = percentage points

About Shin Poong Pharm.Co.Ltd.

KO:019170 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$313.87 Million

₩463.15 Billion KRW

Market Cap Rank

#14694 Global

#465 in Korea

Share Price

₩9400.00

Change (1 day)

+2.17%

52-Week Range

₩7210.00 - ₩15690.00

All Time High

₩197211.54